BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 23758975)

  • 1. Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis.
    Liu LN; Huang PY; Lin ZR; Hu LJ; Liang JZ; Li MZ; Tang LQ; Zeng MS; Zhong Q; Zeng BH
    J Transl Med; 2013 Jun; 11():140. PubMed ID: 23758975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis.
    Wang HY; Li YY; Shao Q; Hou JH; Wang F; Cai MB; Zeng YX; Shao JY
    J Transl Med; 2012 Feb; 10():27. PubMed ID: 22321704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
    Zhou K; Zhao J; Xu H; Yan X; Liu W; Jiang X; Ren C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):685-697. PubMed ID: 35837768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant SATB1 expression is associated with Epstein-Barr virus infection, metastasis and survival in human nasopharyngeal cells and endemic nasopharyngeal carcinoma.
    Deng YF; Zhou DN; Pan ZY; Yin P
    Int J Clin Exp Pathol; 2014; 7(5):2454-61. PubMed ID: 24966956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes.
    Yang Q; Lin H; Wu S; Lei F; Zhu X; Song L; Hong M; Guo L
    PLoS One; 2015; 10(8):e0136448. PubMed ID: 26305455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma.
    Cao JY; Liu L; Chen SP; Zhang X; Mi YJ; Liu ZG; Li MZ; Zhang H; Qian CN; Shao JY; Fu LW; Xia YF; Zeng MS
    Mol Cancer; 2010 Sep; 9():237. PubMed ID: 20828406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axl Is a Potential Cancer Prognostic Marker for the Migration and Invasion of Nasopharyngeal Carcinoma.
    Jiang C; Zhou L; Wang H; Zhang Q; Xu Y
    Adv Clin Exp Med; 2016; 25(3):531-7. PubMed ID: 27629742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
    Tu L; Liu Z; He X; He Y; Yang H; Jiang Q; Xie S; Xiao G; Li X; Yao K; Fang W
    Mol Cancer; 2010 Apr; 9():78. PubMed ID: 20398343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
    Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
    Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix Metalloproteinase 14 Overexpression Is Correlated with the Progression and Poor Prognosis of Nasopharyngeal Carcinoma.
    Yan TH; Lin ZH; Jiang JH; Lu SW; Que HX; Chen MA; He XS; Que GB; Xiao JN; Chen YQ
    Arch Med Res; 2015 Apr; 46(3):186-92. PubMed ID: 25829357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of Caveolin-1 correlate with Akt expression and poor prognosis in NPC patients.
    Wang YP; Lin CF; Tsai SC; Tsai CH; Yeh TH
    Laryngoscope; 2015 Jul; 125(7):E231-8. PubMed ID: 25877996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.
    Liu N; He QM; Chen JW; Li YQ; Xu YF; Ren XY; Sun Y; Mai HQ; Shao JY; Jia WH; Kang TB; Zeng MS; Ma J
    Mol Cancer; 2014 May; 13():111. PubMed ID: 24884612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribonucleotide reductase M2 subunit expression and prognostic value in nasopharyngeal carcinoma.
    Han P; Lin ZR; Xu LH; Zhong Q; Zhu XF; Liang FY; Cai Q; Huang XM; Zeng MS
    Mol Med Rep; 2015 Jul; 12(1):401-9. PubMed ID: 25695839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of Sp1 suppresses cell proliferation, clonogenicity and the expressions of stem cell markers in nasopharyngeal carcinoma.
    Zhang JP; Zhang H; Wang HB; Li YX; Liu GH; Xing S; Li MZ; Zeng MS
    J Transl Med; 2014 Aug; 12():222. PubMed ID: 25099028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis to identify cytokeratin 18 as a novel biomarker of nasopharyngeal carcinoma.
    Li XM; Huang WG; Yi H; Cheng AL; Xiao ZQ
    J Cancer Res Clin Oncol; 2009 Dec; 135(12):1763-75. PubMed ID: 19529960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma.
    Chen YF; Ma G; Cao X; Huang ZL; Zeng MS; Wen ZS
    Med Oncol; 2014 Dec; 31(12):317. PubMed ID: 25377660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
    Zhou J; Wang S; Lu J; Li J; Ding Y
    Int J Cancer; 2009 Apr; 124(8):1879-86. PubMed ID: 19101992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer.
    Wang XJ; Xiong Y; Ma ZB; Xia JC; Li YF
    Chin J Cancer; 2016 Jun; 35(1):54. PubMed ID: 27311570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
    Xu YF; Ren XY; Li YQ; He QM; Tang XR; Sun Y; Shao JY; Jia WH; Kang TB; Zeng MS; Liu N; Ma J
    BMC Cancer; 2015 Apr; 15():332. PubMed ID: 25925041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway.
    Wu Q; Xiang M; Wang K; Chen Z; Long L; Tao Y; Liang Y; Yan Y; Xiao Z; Qiu S; Yi B
    Curr Cancer Drug Targets; 2020; 20(8):624-637. PubMed ID: 32329689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.